1. Home
  2. AVNT vs RARE Comparison

AVNT vs RARE Comparison

Compare AVNT & RARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVNT
  • RARE
  • Stock Information
  • Founded
  • AVNT 1927
  • RARE 2010
  • Country
  • AVNT United States
  • RARE United States
  • Employees
  • AVNT N/A
  • RARE N/A
  • Industry
  • AVNT Major Chemicals
  • RARE Biotechnology: Pharmaceutical Preparations
  • Sector
  • AVNT Industrials
  • RARE Health Care
  • Exchange
  • AVNT Nasdaq
  • RARE Nasdaq
  • Market Cap
  • AVNT 4.4B
  • RARE 5.2B
  • IPO Year
  • AVNT 1993
  • RARE 2014
  • Fundamental
  • Price
  • AVNT $50.64
  • RARE $44.75
  • Analyst Decision
  • AVNT Strong Buy
  • RARE Strong Buy
  • Analyst Count
  • AVNT 5
  • RARE 14
  • Target Price
  • AVNT $54.50
  • RARE $86.79
  • AVG Volume (30 Days)
  • AVNT 519.1K
  • RARE 900.1K
  • Earning Date
  • AVNT 10-31-2024
  • RARE 11-05-2024
  • Dividend Yield
  • AVNT 2.13%
  • RARE N/A
  • EPS Growth
  • AVNT N/A
  • RARE N/A
  • EPS
  • AVNT 1.64
  • RARE N/A
  • Revenue
  • AVNT $3,212,900,000.00
  • RARE $522,745,000.00
  • Revenue This Year
  • AVNT $5.38
  • RARE $27.29
  • Revenue Next Year
  • AVNT $4.41
  • RARE $18.30
  • P/E Ratio
  • AVNT $31.06
  • RARE N/A
  • Revenue Growth
  • AVNT N/A
  • RARE 27.44
  • 52 Week Low
  • AVNT $33.84
  • RARE $37.02
  • 52 Week High
  • AVNT $54.68
  • RARE $60.37
  • Technical
  • Relative Strength Index (RSI)
  • AVNT 55.47
  • RARE 23.47
  • Support Level
  • AVNT $51.00
  • RARE $47.73
  • Resistance Level
  • AVNT $52.27
  • RARE $53.04
  • Average True Range (ATR)
  • AVNT 1.70
  • RARE 2.00
  • MACD
  • AVNT 0.23
  • RARE -0.57
  • Stochastic Oscillator
  • AVNT 56.18
  • RARE 2.46

About AVNT Avient Corporation

Avient Corp manufactures and sells a variety of chemical and plastic-based products to designers and processors of plastics. The firm operates in two segments: Color, Additives and Inks, and Specialty Engineered Materials. The company's product portfolio includes concentrated color and ink blends, plastic resins, and various specialized polymer materials used in industries such as food packaging, construction, transportation, cosmetics, and healthcare. The color, additives, & ink segment and the distribution segment together generate a vast majority of revenue. More than half of the total revenue is derived from the United States.

About RARE Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi, and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.

Share on Social Networks: